{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:04:33Z","timestamp":1783782273531,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10549-019-05258-0","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T17:05:38Z","timestamp":1556903138000},"page":"545-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer"],"prefix":"10.1007","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4192-9644","authenticated-orcid":false,"given":"Evan N.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Ning","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu K.","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanda","family":"Tin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica M.","family":"Gutierrez Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwao","family":"Kiyokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo H.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cristofanilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"issue":"3","key":"5258_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P","volume":"190","author":"FW Orr","year":"2000","unstructured":"Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM (2000) Interactions between cancer cells and the endothelium in metastasis. J Pathol 190(3):310\u2013329. \n                    https:\/\/doi.org\/10.1002\/(SICI)1096-9896(200002)190:3%3c310:AID-PATH525%3e3.0.CO;2-P","journal-title":"J Pathol"},{"key":"5258_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fonc.2015.00300","volume":"5","author":"JL Daniotti","year":"2015","unstructured":"Daniotti JL, Lardone RD, Vilcaes AA (2015) Dysregulated expression of glycolipids in tumor cells: from negative modulator of anti-tumor immunity to promising targets for developing therapeutic agents. Front Oncol 5:300. \n                    https:\/\/doi.org\/10.3389\/fonc.2015.00300","journal-title":"Front Oncol"},{"issue":"5","key":"5258_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1349-7006.2004.tb03219.x","volume":"95","author":"R Kannagi","year":"2004","unstructured":"Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95(5):377\u2013384","journal-title":"Cancer Sci"},{"issue":"2","key":"5258_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10719-018-9820-0","volume":"35","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Wuhrer M, Holst S (2018) Serum sialylation changes in cancer. Glycoconj J 35(2):139\u2013160. \n                    https:\/\/doi.org\/10.1007\/s10719-018-9820-0","journal-title":"Glycoconj J"},{"issue":"6","key":"5258_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/emboj\/18.6.1516","volume":"18","author":"C Ohyama","year":"1999","unstructured":"Ohyama C, Tsuboi S, Fukuda M (1999) Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. EMBO J 18(6):1516\u20131525. \n                    https:\/\/doi.org\/10.1093\/emboj\/18.6.1516","journal-title":"EMBO J"},{"issue":"3","key":"5258_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jjco\/27.3.135","volume":"27","author":"N Matsuura","year":"1997","unstructured":"Matsuura N, Narita T, Mitsuoka C, Kimura N, Kannagi R, Imai T, Funahashi H, Takagi H (1997) Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases. Jpn J Clin Oncol 27(3):135\u2013139","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"5258_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/jjco\/hyq190","volume":"41","author":"T Fujita","year":"2011","unstructured":"Fujita T, Murayama K, Hanamura T, Okada T, Ito T, Harada M, Komatsu A, Koyama H, Kanai T, Maeno K, Mochizuki Y, Hama Y, Ito K, Amano J, Fujimori M (2011) CSLEX (Sialyl Lewis X) is a useful tumor marker for monitoring of breast cancer patients. Jpn J Clin Oncol 41(3):394\u2013399. \n                    https:\/\/doi.org\/10.1093\/jjco\/hyq190","journal-title":"Jpn J Clin Oncol"},{"issue":"3A","key":"5258_CR8","first-page":"1615","volume":"25","author":"U Jeschke","year":"2005","unstructured":"Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K (2005) Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Anticancer Res 25(3A):1615\u20131622","journal-title":"Anticancer Res"},{"issue":"5","key":"5258_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00432-002-0334-5","volume":"128","author":"T Nakagoe","year":"2002","unstructured":"Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, Ayabe H, Hara S, Ishikawa H, Minami H (2002) Expression of ABH\/Lewis-related antigens as prognostic factors in patients with breast cancer. J Cancer Res Clin Oncol 128(5):257\u2013264. \n                    https:\/\/doi.org\/10.1007\/s00432-002-0334-5","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"5258_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/jjco\/hyi235","volume":"36","author":"J Kurebayashi","year":"2006","unstructured":"Kurebayashi J, Nomura T, Hirono M, Okubo S, Udagawa K, Shiiki S, Ikeda M, Nakashima K, Tanaka K, Sonoo H (2006) Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients. Jpn J Clin Oncol 36(3):150\u2013153. \n                    https:\/\/doi.org\/10.1093\/jjco\/hyi235","journal-title":"Jpn J Clin Oncol"},{"issue":"24","key":"5258_CR11","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1158\/0008-5472.CAN-11-1139","volume":"71","author":"S Julien","year":"2011","unstructured":"Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, Sproviero D, Picco G, Gillett C, Papp SL, Schaffer L, Tutt A, Taylor-Papadimitriou J, Pinder SE, Burchell JM (2011) Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Can Res 71(24):7683\u20137693. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1139","journal-title":"Can Res"},{"issue":"3","key":"5258_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2011.05.026","volume":"409","author":"Z Silva","year":"2011","unstructured":"Silva Z, Tong Z, Cabral MG, Martins C, Castro R, Reis C, Trindade H, Konstantopoulos K, Videira PA (2011) Sialyl Lewisx-dependent binding of human monocyte-derived dendritic cells to selectins. Biochem Biophys Res Commun 409(3):459\u2013464. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.026","journal-title":"Biochem Biophys Res Commun"},{"issue":"6B","key":"5258_CR13","first-page":"2523","volume":"15","author":"T Narita","year":"1995","unstructured":"Narita T, Kawakami-Kimura N, Matsuura N, Hosono J, Kannagi R (1995) Corticosteroids and medroxyprogesterone acetate inhibit the induction of E-selectin on the vascular endothelium by MDA-MB-231 breast cancer cells. Anticancer Res 15(6B):2523\u20132527","journal-title":"Anticancer Res"},{"issue":"11","key":"5258_CR14","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1517\/14728222.11.11.1473","volume":"11","author":"SR Barthel","year":"2007","unstructured":"Barthel SR, Gavino JD, Descheny L, Dimitroff CJ (2007) Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Therap Targets 11(11):1473\u20131491. \n                    https:\/\/doi.org\/10.1517\/14728222.11.11.1473","journal-title":"Expert Opin Therap Targets"},{"issue":"1","key":"5258_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12307-010-0043-6","volume":"3","author":"H Laubli","year":"2010","unstructured":"Laubli H, Borsig L (2010) Selectins as mediators of lung metastasis. Cancer Microenviron 3(1):97\u2013105. \n                    https:\/\/doi.org\/10.1007\/s12307-010-0043-6","journal-title":"Cancer Microenviron"},{"issue":"3","key":"5258_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.semcancer.2010.04.005","volume":"20","author":"H Laubli","year":"2010","unstructured":"Laubli H, Borsig L (2010) Selectins promote tumor metastasis. Semin Cancer Biol 20(3):169\u2013177. \n                    https:\/\/doi.org\/10.1016\/j.semcancer.2010.04.005","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"5258_CR17","first-page":"1305","volume":"26","author":"SV Portela","year":"2011","unstructured":"Portela SV, Martin CV, Romay LM, Cuevas E, Martin EG, Briera AF (2011) sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis. Histol Histopathol 26(10):1305\u20131316","journal-title":"Histol Histopathol"},{"issue":"8","key":"5258_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/jso.23002","volume":"105","author":"T Iwata","year":"2012","unstructured":"Iwata T, Nishiyama N, Nagano K, Izumi N, Tsukioka T, Chung K, Hanada S, Inoue K, Kaji M, Suehiro S (2012) Preoperative serum value of sialyl Lewis X predicts pathological nodal extension and survival in patients with surgically treated small cell lung cancer. J Surg Oncol 105(8):818\u2013824. \n                    https:\/\/doi.org\/10.1002\/jso.23002","journal-title":"J Surg Oncol"},{"issue":"11","key":"5258_CR19","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1182\/blood-2007-12-130120","volume":"111","author":"A Ferrajoli","year":"2008","unstructured":"Ferrajoli A, Lee BN, Schlette EJ, O\u2019Brien SM, Gao H, Wen S, Wierda WG, Estrov Z, Faderl S, Cohen EN, Li C, Reuben JM, Keating MJ (2008) Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood 111(11):5291\u20135297. \n                    https:\/\/doi.org\/10.1182\/blood-2007-12-130120","journal-title":"Blood"},{"issue":"4","key":"5258_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1066896908324668","volume":"16","author":"P Sozzani","year":"2008","unstructured":"Sozzani P, Arisio R, Porpiglia M, Benedetto C (2008) Is Sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer? Int J Surg Pathol 16(4):365\u2013374. \n                    https:\/\/doi.org\/10.1177\/1066896908324668","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"5258_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbamcr.2010.12.010","volume":"1813","author":"Z Culig","year":"2011","unstructured":"Culig Z (2011) Cytokine disbalance in common human cancers. Biochim Biophys Acta 1813(2):308\u2013314. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2010.12.010","journal-title":"Biochim Biophys Acta"},{"key":"5258_CR22","first-page":"107","volume":"15","author":"B Walzog","year":"2000","unstructured":"Walzog B, Gaehtgens P (2000) Adhesion molecules: the path to a new understanding of acute inflammation. News Physiol Sci 15:107\u2013113","journal-title":"News Physiol Sci"},{"issue":"2","key":"5258_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10549-006-9328-3","volume":"102","author":"H Knupfer","year":"2007","unstructured":"Knupfer H, Preiss R (2007) Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat 102(2):129\u2013135. \n                    https:\/\/doi.org\/10.1007\/s10549-006-9328-3","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"5258_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ijc.10833","volume":"103","author":"R Salgado","year":"2003","unstructured":"Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY (2003) Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103(5):642\u2013646. \n                    https:\/\/doi.org\/10.1002\/ijc.10833","journal-title":"Int J Cancer"},{"issue":"21","key":"5258_CR25","doi-asserted-by":"publisher","first-page":"7157","DOI":"10.1158\/1078-0432.CCR-04-0812","volume":"10","author":"IH Benoy","year":"2004","unstructured":"Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpe S, Vermeulen PB, Dirix LY (2004) Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10(21):7157\u20137162. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0812","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5258_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/bcr3436","volume":"15","author":"JK Singh","year":"2013","unstructured":"Singh JK, Simoes BM, Howell SJ, Farnie G, Clarke RB (2013) Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res 15(4):210. \n                    https:\/\/doi.org\/10.1186\/bcr3436","journal-title":"Breast Cancer Res"},{"issue":"9","key":"5258_CR27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2174\/138945010792006799","volume":"11","author":"JE Goldberg","year":"2010","unstructured":"Goldberg JE, Schwertfeger KL (2010) Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics. Curr Drug Targets 11(9):1133\u20131146","journal-title":"Curr Drug Targets"},{"issue":"5","key":"5258_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cytogfr.2006.07.002","volume":"17","author":"A Nicolini","year":"2006","unstructured":"Nicolini A, Carpi A, Rossi G (2006) Cytokines in breast cancer. Cytokine Growth Factor Rev 17(5):325\u2013337. \n                    https:\/\/doi.org\/10.1016\/j.cytogfr.2006.07.002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2B","key":"5258_CR29","first-page":"1427","volume":"19","author":"GJ Zhang","year":"1999","unstructured":"Zhang GJ, Adachi I (1999) Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19(2B):1427\u20131432","journal-title":"Anticancer Res"},{"issue":"1","key":"5258_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cyto.2008.08.002","volume":"44","author":"G Soria","year":"2008","unstructured":"Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L, Cohen-Hillel E, Shtabsky A, Ehrlich M, Meshel T, Keydar I, Ben-Baruch A (2008) Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions. Cytokine 44(1):191\u2013200. \n                    https:\/\/doi.org\/10.1016\/j.cyto.2008.08.002","journal-title":"Cytokine"},{"issue":"2","key":"5258_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","volume":"267","author":"G Soria","year":"2008","unstructured":"Soria G, Ben-Baruch A (2008) The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267(2):271\u2013285. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2008.03.018","journal-title":"Cancer Lett"},{"issue":"12","key":"5258_CR32","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.4049\/jimmunol.1300434","volume":"190","author":"T Lan\u00e7a","year":"2013","unstructured":"Lan\u00e7a T, Costa MF, Gon\u00e7alves-Sousa N, Rei M, Grosso AR, Penido C, Silva-Santos B (2013) Protective role of the inflammatory CCR32\/CCL2 chemokine pathway through recruitment of type 1 cytotoxic \u03b3\u03b4 T lymphocytes to tumor beds. J Immunol 190(12):6673\u20136680. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1300434","journal-title":"J Immunol"},{"issue":"8","key":"5258_CR33","first-page":"3282","volume":"6","author":"T Ueno","year":"2000","unstructured":"Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6(8):3282\u20133289","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5258_CR34","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/bcr1648","volume":"9","author":"C Chavey","year":"2007","unstructured":"Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissiere F, Laune D, Roques S, Lazennec G (2007) Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 9(1):R15. \n                    https:\/\/doi.org\/10.1186\/bcr1648","journal-title":"Breast Cancer Res"},{"key":"5258_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz HJ (2018) CXCL9, CXCL10, CXCL11\/CXCR35 axis for immune activation\u2014A target for novel cancer therapy. Cancer Treat Rev 63:40\u201347. \n                    https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007","journal-title":"Cancer Treat Rev"},{"issue":"13","key":"5258_CR36","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1158\/0008-5472.CAN-12-0481","volume":"72","author":"JH Lee","year":"2012","unstructured":"Lee JH, Kim HN, Kim KO, Jin WJ, Lee S, Kim HH, Ha H, Lee ZH (2012) CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis. Can Res 72(13):3175\u20133186. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0481","journal-title":"Can Res"},{"issue":"4","key":"5258_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/ol.2011.300","volume":"2","author":"M Liu","year":"2011","unstructured":"Liu M, Guo S, Stiles JK (2011) The emerging role of CXCL10 in cancer (Review). Oncol Lett 2(4):583\u2013589. \n                    https:\/\/doi.org\/10.3892\/ol.2011.300","journal-title":"Oncol Lett"},{"issue":"5","key":"5258_CR38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/bjc.2016.172","volume":"115","author":"H Bronger","year":"2016","unstructured":"Bronger H, Singer J, Windmuller C, Reuning U, Zech D, Delbridge C, Dorn J, Kiechle M, Schmalfeldt B, Schmitt M, Avril S (2016) CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer. Br J Cancer 115(5):553\u2013563. \n                    https:\/\/doi.org\/10.1038\/bjc.2016.172","journal-title":"Br J Cancer"},{"issue":"4","key":"5258_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3233\/CBM-160596","volume":"16","author":"A Jafarzadeh","year":"2016","unstructured":"Jafarzadeh A, Fooladseresht H, Nemati M, Assadollahi Z, Sheikhi A, Ghaderi A (2016) Higher circulating levels of chemokine CXCL10 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism. Cancer Biomark 16(4):545\u2013554. \n                    https:\/\/doi.org\/10.3233\/CBM-160596","journal-title":"Cancer Biomark"},{"issue":"2","key":"5258_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3892\/ijo.2011.1247","volume":"40","author":"Y Toiyama","year":"2012","unstructured":"Toiyama Y, Fujikawa H, Kawamura M, Matsushita K, Saigusa S, Tanaka K, Inoue Y, Uchida K, Mohri Y, Kusunoki M (2012) Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer. Int J Oncol 40(2):560\u2013566. \n                    https:\/\/doi.org\/10.3892\/ijo.2011.1247","journal-title":"Int J Oncol"},{"issue":"2","key":"5258_CR41","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/hep.24098","volume":"53","author":"ML Berres","year":"2011","unstructured":"Berres ML, Trautwein C, Schmeding M, Eurich D, Tacke F, Bahra M, Neuhaus P, Neumann UP, Wasmuth HE (2011) Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. Hepatology 53(2):596\u2013603. \n                    https:\/\/doi.org\/10.1002\/hep.24098","journal-title":"Hepatology"},{"issue":"9","key":"5258_CR42","doi-asserted-by":"publisher","first-page":"e1322242","DOI":"10.1080\/2162402X.2017.1322242","volume":"6","author":"G Piro","year":"2017","unstructured":"Piro G, Simionato F, Carbone C, Frizziero M, Malleo G, Zanini S, Casolino R, Santoro R, Mina MM, Zecchetto C, Merz V, Scarpa A, Bassi C, Tortora G, Melisi D (2017) A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma. Oncoimmunology 6(9):e1322242. \n                    https:\/\/doi.org\/10.1080\/2162402X.2017.1322242","journal-title":"Oncoimmunology"},{"issue":"4","key":"5258_CR43","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/annonc\/mdr319","volume":"23","author":"S Dawood","year":"2012","unstructured":"Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Cristofanilli M (2012) Identifying factors that impact survival among women with inflammatory breast cancer. Ann Oncol 23(4):870\u2013875. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdr319","journal-title":"Ann Oncol"},{"issue":"4","key":"5258_CR44","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/S1470-2045(17)30192-4","volume":"18","author":"TM Fouad","year":"2017","unstructured":"Fouad TM, Barrera AMG, Reuben JM, Lucci A, Woodward WA, Stauder MC, Lim B, DeSnyder SM, Arun B, Gildy B, Valero V, Hortobagyi GN, Ueno NT (2017) Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system. Lancet Oncol 18(4):e228\u2013e232. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(17)30192-4","journal-title":"Lancet Oncol"},{"issue":"2","key":"5258_CR45","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0002-9440(10)64217-4","volume":"161","author":"ML Alpaugh","year":"2002","unstructured":"Alpaugh ML, Tomlinson JS, Ye Y, Barsky SH (2002) Relationship of sialyl-Lewis(x\/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. Am J Pathol 161(2):619\u2013628. \n                    https:\/\/doi.org\/10.1016\/S0002-9440(10)64217-4","journal-title":"Am J Pathol"},{"issue":"2","key":"5258_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/1536867x1201200202","volume":"12","author":"RM Conroy","year":"2012","unstructured":"Conroy RM (2012) What hypotheses do \u201cnonparametric\u201d two-group tests actually test? Stata J 12(2):182\u2013190. \n                    https:\/\/doi.org\/10.1177\/1536867x1201200202","journal-title":"Stata J"},{"issue":"11","key":"5258_CR47","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1373\/clinchem.2016.260968","volume":"62","author":"J Yamashita","year":"2016","unstructured":"Yamashita J, Kobayashi I, Tatematsu K, Sezutsu H, Noda K, Ishihara H (2016) Sandwich elisa using a mouse\/human chimeric CSLEX-1 antibody. Clin Chem 62(11):1516\u20131523. \n                    https:\/\/doi.org\/10.1373\/clinchem.2016.260968","journal-title":"Clin Chem"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05258-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05258-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05258-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:24:03Z","timestamp":1588375443000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05258-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["5258"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05258-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"31 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MC has received research Grants from Nittobi Medical, Co. TM, IK and JK are employed by Nittobi Medical, Co. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The project was approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}